Literature DB >> 16284673

The incidence and patterns of BCR/ABL rearrangements in chronic myeloid leukaemia (CML) using fluorescence in situ hybridisation (FISH).

T H Lim1, S L Tien, P Lim, A S T Lim.   

Abstract

INTRODUCTION: Chronic myeloid leukaemia (CML) is characterised by the formation of the BCR/ABL fusion gene, usually as a result of the Philadelphia (Ph) translocation between chromosomes 9 and 22.
MATERIALS AND METHODS: The incidence of both typical and atypical BCR/ ABL gene rearrangements was determined in 110 patients suspected of CML using dual fusion fluorescence in situ hybridisation (DF-FISH) probes.
RESULTS: Eighty-seven per cent of CML patients showed Ph translocation while 13% were negative for the Ph chromosome. About 71.9% of Ph-positive patients displayed the typical DF-FISH signal pattern. Atypical patterns among the Ph-positive patients included the concurrent loss of residual proximal 9q and distal 22q (10.4%), complex translocation with additional partners (9.4%), supernumerary Ph (3.1%), loss of residual 9q sequences proximal to breakpoint (3.1%), and deletion of distal derivative 22q signal (2.1%). Cryptic genetic alterations with loss of proximal 9q sequences were found in 13.5% of CML Ph-positive patients, which is associated with poor prognosis. Fusion signals were detected in 57.1% of CML Ph-negative patients, indicating cryptic BCR/ABL rearrangements (i.e., masked Ph).
CONCLUSION: FISH is able to detect BCR/ABL fusion in CML with masked or variant Ph not apparent with conventional karyotyping. Establishment of signal patterns with FISH is important as atypical patterns may have clinical prognostic implications.

Entities:  

Mesh:

Year:  2005        PMID: 16284673

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  5 in total

1.  Anti-tumor activity of Eurycoma longifolia root extracts against K-562 cell line: in vitro and in vivo study.

Authors:  Omar Saeed Ali Al-Salahi; Dan Ji; Amin Malik Shah Abdul Majid; Chan Kit-Lam; Wan Zaidah Abdullah; Abdelhamid Zaki; Shah Kamal Khan Jamal Din; Narazah Mohd Yusoff; Aman Shah Abdul Majid
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

2.  Reliability Evaluation of Fluorescence In Situ Hybridization (FISH) and G-Banding on Bone Marrow and Peripheral Blood Cells in Chronic Myelogenous Leukemia Patients.

Authors:  Soheila Manaflouyan Khajehmarjany; Seyed Ali Rahmani; Seyed Hadi Chavoshi; Ali Esfahani; Ali Akbar Movassaghpour Akbari
Journal:  Cell J       Date:  2015-04-08       Impact factor: 2.479

3.  Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.

Authors:  Simona Luatti; Carmen Baldazzi; Giulia Marzocchi; Gaia Ameli; Maria Teresa Bochicchio; Simona Soverini; Fausto Castagnetti; Mario Tiribelli; Gabriele Gugliotta; Giovanni Martinelli; Michele Baccarani; Michele Cavo; Gianantonio Rosti; Nicoletta Testoni
Journal:  Oncotarget       Date:  2017-05-02

4.  Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods.

Authors:  Brian J Haas; Alexander Dobin; Bo Li; Nicolas Stransky; Nathalie Pochet; Aviv Regev
Journal:  Genome Biol       Date:  2019-10-21       Impact factor: 13.583

5.  The incidence of atypical patterns of BCR-ABL1 rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML).

Authors:  Željka Tkalčić Švabek; Marina Josipović; Ivana Horvat; Renata Zadro; Sanja Davidović-Mrsić
Journal:  Blood Res       Date:  2018-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.